1. Home
  2. LAMR vs STXS Comparison

LAMR vs STXS Comparison

Compare LAMR & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAMR
  • STXS
  • Stock Information
  • Founded
  • LAMR 1902
  • STXS 1990
  • Country
  • LAMR United States
  • STXS United States
  • Employees
  • LAMR N/A
  • STXS N/A
  • Industry
  • LAMR Real Estate Investment Trusts
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • LAMR Real Estate
  • STXS Health Care
  • Exchange
  • LAMR Nasdaq
  • STXS Nasdaq
  • Market Cap
  • LAMR N/A
  • STXS 151.3M
  • IPO Year
  • LAMR 1996
  • STXS 2004
  • Fundamental
  • Price
  • LAMR $114.75
  • STXS $2.12
  • Analyst Decision
  • LAMR Hold
  • STXS
  • Analyst Count
  • LAMR 6
  • STXS 0
  • Target Price
  • LAMR $130.67
  • STXS N/A
  • AVG Volume (30 Days)
  • LAMR 761.9K
  • STXS 285.8K
  • Earning Date
  • LAMR 05-08-2025
  • STXS 05-12-2025
  • Dividend Yield
  • LAMR 5.12%
  • STXS N/A
  • EPS Growth
  • LAMR N/A
  • STXS N/A
  • EPS
  • LAMR 4.11
  • STXS N/A
  • Revenue
  • LAMR $2,219,477,000.00
  • STXS $26,918,000.00
  • Revenue This Year
  • LAMR $4.06
  • STXS $25.90
  • Revenue Next Year
  • LAMR $3.91
  • STXS $60.57
  • P/E Ratio
  • LAMR $28.04
  • STXS N/A
  • Revenue Growth
  • LAMR 3.68
  • STXS 0.55
  • 52 Week Low
  • LAMR $99.84
  • STXS $1.54
  • 52 Week High
  • LAMR $139.88
  • STXS $2.72
  • Technical
  • Relative Strength Index (RSI)
  • LAMR 52.57
  • STXS 68.07
  • Support Level
  • LAMR $112.00
  • STXS $1.93
  • Resistance Level
  • LAMR $118.88
  • STXS $2.07
  • Average True Range (ATR)
  • LAMR 2.54
  • STXS 0.09
  • MACD
  • LAMR 0.60
  • STXS 0.03
  • Stochastic Oscillator
  • LAMR 58.87
  • STXS 93.42

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: